US FDA authorizes Moderna Covid-19 vaccine mRNA-1273
Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine candidate of Moderna. The FDA authorization is for the use of mRNA-1273 in individuals aged 18 years and more for the prevention of Covid-19 caused by severe acute respiratory syndrome […]
Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt
August 12, 2020 No Comment
Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million doses of its mRNA-1273 vaccine candidate for Covid-19 to the US government. The US biotech company said that the award for the mRNA vaccine candidate includes incentive payments for the timely supply of the product. As per […]
Continue reading …
Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer levels in all eight initial participants across the 25 µg and 100 µg dose cohorts. The early-stage clinical trial in humans was led by the US National Institute of Allergy […]
Continue reading …
Business News Today
- EBRD, and others launch construction on wastewater pipeline in Amman
- Bureau Veritas acquires Canadian food auditing business of Orion Assessment Services
- Fedeli Group acquires Medicare-focused KAZ Company
- TCS rolls out curated version of Cloud Assurance Platform services for Microsoft Azure
- ICICI Bank launches InstaFX app for authorized money changers
- Bank Audi sal to sell Egyptian subsidiary to First Abu Dhabi Bank
- SEBI approves Reliance Industries acquisition of Big Bazaar and other businesses of Future Group
- Royal Caribbean Group to sell Azamara cruise brand to Sycamore Partners for $201m
- ONGC distributes solar chulhas in Betul district, Madhya Pradesh
- Citi merges wealth management units to create Citi Global Wealth
